671 related articles for article (PubMed ID: 11709301)
1. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
[TBL] [Abstract][Full Text] [Related]
2. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.
Chami F; Chami N; Bennis S; Trouillas J; Remmal A
J Antimicrob Chemother; 2004 Nov; 54(5):909-14. PubMed ID: 15456732
[TBL] [Abstract][Full Text] [Related]
4. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.
Jimenez E; Martínez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D
Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948
[TBL] [Abstract][Full Text] [Related]
6. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E
Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
Liao H; Liu S; Wang H; Su H; Liu Z
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
[TBL] [Abstract][Full Text] [Related]
9. Novel Preclinical Study of Galloylquinic Acid Compounds from
Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Syngonanthus nitens (Bong.) Ruhl. extract as antifungal and in treatment of vulvovaginal candidiasis.
de Freitas Araújo MG; Pacífico M; Vilegas W; Dos Santos LC; Icely PA; Miró MS; Scarpa MV; Bauab TM; Sotomayor CE
Med Mycol; 2013 Oct; 51(7):673-82. PubMed ID: 23758104
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activities and cytotoxicity studies of six new azasordarins.
Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
[TBL] [Abstract][Full Text] [Related]
12. Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment.
de Freitas ALD; Kaplum V; Rossi DCP; da Silva LBR; Melhem MSC; Taborda CP; de Mello JCP; Nakamura CV; Ishida K
J Ethnopharmacol; 2018 Apr; 216():184-190. PubMed ID: 29325916
[TBL] [Abstract][Full Text] [Related]
13. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
14. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
[TBL] [Abstract][Full Text] [Related]
15. Formulation, stability study and preclinical evaluation of a vaginal cream containing curcumin in a rat model of vulvovaginal candidiasis.
Fernandes LS; Amorim YM; da Silva EL; Silva SC; Santos AJA; Peixoto FN; Neves Pires LM; Sakamoto RY; Horta Pinto FDC; Scarpa MVC; Araújo MGF
Mycoses; 2018 Oct; 61(10):723-730. PubMed ID: 29517833
[TBL] [Abstract][Full Text] [Related]
16. Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.
Wang L; Wang C; Mei H; Shen Y; Lv G; Zeng R; Zhan P; Li D; Liu W
Mycopathologia; 2016 Feb; 181(1-2):29-39. PubMed ID: 26404163
[TBL] [Abstract][Full Text] [Related]
17. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
Hayama K; Ishibashi H; Ishijima SA; Niimi K; Tansho S; Ono Y; Monk BC; Holmes AR; Harding DR; Cannon RD; Abe S
FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Zhang H; Wang K; Zhang G; Ho HI; Gao A
Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
[TBL] [Abstract][Full Text] [Related]
19. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
Karaman M; Kiray M; Bayrakal V; Bağrıyanık HA; Yılmaz O; Bahar IH
Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
[TBL] [Abstract][Full Text] [Related]
20. Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis.
Martinez A; Aviles P; Jimenez E; Caballero J; Gargallo-Viola D
Antimicrob Agents Chemother; 2000 Dec; 44(12):3389-94. PubMed ID: 11083645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]